SIM
WST icon

Spark Investment Management’s West Pharmaceutical WST Stock Holding History

Spark Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,800
Closed -$2.91M – 817
2017
Q2 		$2.91M Hold
30,800
– – 0.18% 185
2017
Q1 		$2.51M Buy
+30,800
New +$2.58M 0.16% 212
2014
Q4 		– Sell
-22,100
Closed -$989K – 812
2014
Q3 		$989K Sell
22,100
-24,400
-52% -$1.04M 0.15% 210
2014
Q2 		$1.96M Sell
46,500
-8,900
-16% -$381K 0.29% 108
2014
Q1 		$2.44M Buy
55,400
+10,500
+23% +$494K 0.38% 67
2013
Q4 		$2.2M Buy
44,900
+11,500
+34% +$538K 0.38% 62
2013
Q3 		$1.37M Buy
33,400
+12,600
+61% +$481K 0.31% 91
2013
Q2 		$730K Buy
+20,800
New +$684K 0.2% 147

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Spark Investment Management's WST Position: Q3 2017 in Review

Spark Investment Management sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 30,800 shares — an estimated $2.91M sold.

Spark Investment Management first reported a position in WST in Q2 2013 and held it in 8 quarters. The position peaked at $2.91M in Q2 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Spark Investment Management reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Spark Investment Management sold 30,800 West Pharmaceutical shares in Q3 2017, an estimated $2.91M.
  • Spark Investment Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 8 quarters.
  • Spark Investment Management's West Pharmaceutical position peaked at $2.91M in Q2 2017.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Spark Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.